speb/financial-data huggingface dataset:
Financial ratios for CGX.DE — annual report dated 2024-12-31
Total revenue: 120113.78125
Gross profit: -560179.0208333334
Operating income: -15016152.802083334
Net income: -20118470.552083336
Capital expenditures: 0
Depreciation & amortization: 0
Net tangible assets: 27537990.760416668
Owner earnings: -20118470.552083336
Return on net tangible assets (%): -73.05714758609692
Buffett classification: The Gruesome
Stock price: 8.333333333333334
Shares outstanding: 6000000
Book value: 27537990.760416668
P/B ratio: 1.8156734975694162
Market cap (USD): 50000000
Debt to equity: 0.3593080147985697
Current ratio: 0.4525805976575537
Quick ratio: 0.37771527666418736
Interest coverage ratio: -24.985170509605553
COGS to revenue (%): 566.3736458911399
SG&A to revenue (%): 1079.7054147356635
Buyback yield (%): 0
Retained earnings: -20420806.25
Inventory turnover: 0.65308109
Receivables turnover: 20.694405958363244
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -37.52832583507379
Revenue growth (%): -3.2984227303588702
Rule of 40 score: -3.2984227303588702
Financial ratios for CGX.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 27537990.760416668
Buffett classification: The Gruesome
Stock price: 8.333333333333334
Shares outstanding: 6000000
Book value: 27537990.760416668
P/B ratio: 1.8156734975694162
Market cap (USD): 50000000
Debt to equity: 0.3593080147985697
Current ratio: 0.4525805976575537
Quick ratio: 0.37771527666418736
Buyback yield (%): 0
Retained earnings: -20420806.25
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMCM — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.85
Shares outstanding: 10224887
Market cap (USD): 70040475.95
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMCM — annual report dated 2022-12-31
Total revenue: 127020977.01149425
Gross profit: 90733477.01149425
Operating income: -32412500
Net income: -73775143.67816092
Capital expenditures: 105316.091954023
Operating cash flow: -60955316.09195402
Depreciation & amortization: 7618534.482758621
Net tangible assets: 434612212.6436782
Owner earnings: -66261925.287356324
Return on net tangible assets (%): -15.246217975398203
Buffett classification: The Gruesome
Stock price: 1.84
Shares outstanding: 10224887
Book value: 446089942.52873564
P/B ratio: 0.042174885121486635
Market cap (USD): 18813792.080000002
Debt to equity: 0.013358086515463545
Current ratio: 1.7563382506984713
Quick ratio: 1.7469512692244762
COGS to revenue (%): 28.568115955143618
R&D to revenue (%): 20.46872066112711
SG&A to revenue (%): 78.18307682910553
Free cash flow (dilution-adjusted): -63059626.436781615
Buyback yield (%): 0
Retained earnings: -1354022.9885057472
Inventory turnover: 15.12794249775382
Receivables turnover: 1.830845791750626
Capitalized R&D asset: 25999568.96551724
ROCI (R&D-adjusted, %): -2.9632262696687524
FCF margin (%): -49.64504912529156
Rule of 40 score: -49.64504912529156
Financial ratios for CMCM — annual report dated 2023-12-31
Total revenue: 94163572.43319269
Gross profit: 61541912.79887482
Operating income: -29512939.52180028
Net income: -83525879.04360056
Capital expenditures: 3104219.4092827
Operating cash flow: 77420815.75246131
Depreciation & amortization: 4959493.670886076
Net tangible assets: 233519409.28270042
Owner earnings: -81670604.78199719
Return on net tangible assets (%): -34.97379726715826
Buffett classification: The Gruesome
Stock price: 2.28
Shares outstanding: 10224887
Book value: 374199156.11814344
P/B ratio: 0.06230036059365035
Market cap (USD): 23312742.36
Debt to equity: 0.013528751133221778
Current ratio: 1.2707938910871672
Quick ratio: 1.255921880985065
COGS to revenue (%): 34.64360876650291
R&D to revenue (%): 26.61780455053973
SG&A to revenue (%): 70.50901937706028
Free cash flow (dilution-adjusted): 71340084.38818565
Buyback yield (%): 0
Retained earnings: -86230942.3347398
Inventory turnover: 5.71660956793927
Receivables turnover: 0.5237714504766338
Capitalized R&D asset: 42483986.87496969
ROCI (R&D-adjusted, %): -4.759792485419736
Rosenberg metric: -1.122771083295099
FCF margin (%): 75.76187111932283
Revenue growth (%): -25.86769945512879
Rule of 40 score: 49.89417166419405
Financial ratios for CMCM — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.27
Shares outstanding: 10224887
Market cap (USD): 43660267.489999995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMCM — annual report dated 2024-12-31
Total revenue: 110531095.89041096
Gross profit: 74684246.57534246
Operating income: -38954109.5890411
Net income: -82409041.09589042
Capital expenditures: 2640273.97260274
Operating cash flow: -32646986.301369864
Depreciation & amortization: 7048356.164383561
Net tangible assets: 176141643.83561644
Owner earnings: -78000958.9041096
Return on net tangible assets (%): -44.283087863596705
Buffett classification: The Gruesome
Stock price: 4.6
Shares outstanding: 10224887
Book value: 302346027.3972603
P/B ratio: 0.15556506763093722
Market cap (USD): 47034480.199999996
Debt to equity: 0.011603324866817751
Current ratio: 1.2264596348669812
Quick ratio: 1.2112969740549377
COGS to revenue (%): 32.4314610529238
R&D to revenue (%): 30.164572791144128
SG&A to revenue (%): 72.72558270963233
Free cash flow (dilution-adjusted): -39349452.05479452
Buyback yield (%): 0
Retained earnings: -168846164.38356164
Inventory turnover: 5.600111282314672
Receivables turnover: 0.4657978914092505
Capitalized R&D asset: 58714155.332942024
ROCI (R&D-adjusted, %): -8.64076350539454
Rosenberg metric: 0.5243452454206903
FCF margin (%): -35.600345529739975
Revenue growth (%): 17.382011997081705
Rule of 40 score: -18.21833353265827
Financial ratios for CMCM — quarterly report dated 2024-12-31
Total revenue: 32477945.205479454
Gross profit: 23667397.260273974
Operating income: -7430547.94520548
Net income: -49708356.16438356
Capital expenditures: 0
Net tangible assets: 176141643.83561644
Owner earnings: -49708356.16438356
Return on net tangible assets (%): -28.220672341841947
Buffett classification: The Gruesome
Stock price: 4.6
Shares outstanding: 10224887
Book value: 302346027.3972603
P/B ratio: 0.15556506763093722
Market cap (USD): 47034480.199999996
Debt to equity: 0.011603324866817751
Current ratio: 1.2264596348669812
Quick ratio: 1.2112969740549377
COGS to revenue (%): 27.12778745534377
R&D to revenue (%): 27.629286892264087
SG&A to revenue (%): 67.96266380979294
Buyback yield (%): 0
Retained earnings: -168846164.38356164
Inventory turnover: 1.3764124293785311
Receivables turnover: 0.1368678947055472
Capitalized R&D asset: 8973424.657534247
ROCI (R&D-adjusted, %): -0.4249285712180393
Rule of 40 score: 0
Financial ratios for CMCM — quarterly report dated 2025-03-31
Total revenue: 35675757.57575758
Gross profit: 26102066.11570248
Operating income: -3654958.6776859504
Net income: -3871763.0853994493
Capital expenditures: 0
Net tangible assets: 174731404.95867768
Owner earnings: -3871763.0853994493
Return on net tangible assets (%): -2.2158369792282526
Buffett classification: The Gruesome
Stock price: 4.27
Shares outstanding: 10224887
Book value: 301238429.75206614
P/B ratio: 0.14493591513517887
Market cap (USD): 43660267.489999995
Debt to equity: 0
Current ratio: 1.2807801993731067
Quick ratio: 1.2807801993731067
COGS to revenue (%): 26.835285669057857
R&D to revenue (%): 23.645784267545924
SG&A to revenue (%): 60.79473062400099
Buyback yield (%): 0
Retained earnings: -174371074.3801653
Receivables turnover: 0.5153773907783411
Capitalized R&D asset: 14448007.192724254
ROCI (R&D-adjusted, %): -0.2964601741238898
Rosenberg metric: 0.2713199194673479
Revenue growth (%): 9.846104333406569
Rule of 40 score: 9.846104333406569
Financial ratios for CMCM — quarterly report dated 2025-06-30
Total revenue: 41174058.577405855
Gross profit: 31351743.375174336
Operating income: -1542956.7642956765
Net income: -2293305.439330544
Capital expenditures: 0
Net tangible assets: 172717433.75174338
Owner earnings: -2293305.439330544
Return on net tangible assets (%): -1.3277787826716105
Buffett classification: The Gruesome
Stock price: 4.68
Shares outstanding: 10224887
Book value: 302015620.6415621
P/B ratio: 0.15844369591992802
Market cap (USD): 47852471.16
Debt to equity: 0
Current ratio: 1.247766018644914
Quick ratio: 1.247766018644914
COGS to revenue (%): 23.855591461225266
R&D to revenue (%): 22.723207934475546
SG&A to revenue (%): 57.266494590438256
Buyback yield (%): 0
Retained earnings: -179717852.16178522
Receivables turnover: 0.5320949782092274
Capitalized R&D asset: 17969291.572951123
ROCI (R&D-adjusted, %): -0.3176467353690188
Rosenberg metric: 0.6223084204781802
Revenue growth (%): 15.411868942019295
Rule of 40 score: 15.411868942019295
Financial ratios for CMCM — quarterly report dated 2025-09-30
Total revenue: 40360814.60674157
Gross profit: 30107303.370786518
Operating income: 552247.1910112359
Net income: -520224.71910112357
Capital expenditures: 0
Net tangible assets: 161689887.64044943
Owner earnings: -520224.71910112357
Return on net tangible assets (%): -0.3217422726261952
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.06
Shares outstanding: 10224887
Book value: 306934410.1123595
P/B ratio: 0.26850228095908574
Market cap (USD): 82412589.22
Debt to equity: 0
Current ratio: 1.2699576273152982
Quick ratio: 1.2699576273152982
Effective tax rate (%): 137.78820648847173
COGS to revenue (%): 25.404619148203185
R&D to revenue (%): 23.649732573798847
SG&A to revenue (%): 49.753452877659036
Buyback yield (%): 0
Retained earnings: -182521207.86516854
Receivables turnover: 0.5039262792410479
Capitalized R&D asset: 18597607.754475795
ROCI (R&D-adjusted, %): 0.27751236655740374
Rosenberg metric: -0.13300888200379613
Revenue growth (%): -1.9751367700014648
Rule of 40 score: -1.9751367700014648
Financial ratios for CMCM — annual report dated 2025-12-31
Total revenue: 164349142.85714287
Gross profit: 119147571.42857143
Operating income: -19697142.85714286
Net income: -33593142.85714286
Capital expenditures: 1835000
Operating cash flow: -24608000
Depreciation & amortization: 21033571.42857143
Net tangible assets: 156223714.2857143
Owner earnings: -14394571.42857143
Return on net tangible assets (%): -9.214075785092074
Buffett classification: The Gruesome
Stock price: 6
Shares outstanding: 10224887
Book value: 279764000.00000006
P/B ratio: 0.21928955119314844
Market cap (USD): 61349322
Debt to equity: 0.007784622549209842
Current ratio: 1.2684617620443472
Quick ratio: 1.2474163437464085
COGS to revenue (%): 27.503381303218582
R&D to revenue (%): 30.088557113601354
SG&A to revenue (%): 54.69688224720195
Free cash flow (dilution-adjusted): -29277285.714285713
Buyback yield (%): 0
Retained earnings: -212992428.57142857
Inventory turnover: 5.8973589547648775
Receivables turnover: 0.7661689156700325
Capitalized R&D asset: 80060122.71214712
ROCI (R&D-adjusted, %): -1.6101335858729606
Rosenberg metric: 1.3335837045271661
FCF margin (%): -17.814078738295823
Revenue growth (%): 48.690412895291715
Rule of 40 score: 30.876334156995892
Financial ratios for CMCM — quarterly report dated 2025-12-31
Total revenue: 44121571.428571425
Gross profit: 29339428.57142857
Operating income: -14887714.285714285
Net income: -26699428.57142857
Capital expenditures: 0
Net tangible assets: 156223714.2857143
Owner earnings: -26699428.57142857
Return on net tangible assets (%): -17.090509397695243
Buffett classification: The Gruesome
Stock price: 6
Shares outstanding: 10224887
Book value: 279764000.00000006
P/B ratio: 0.21928955119314844
Market cap (USD): 61349322
Debt to equity: 0.007784622549209842
Current ratio: 1.2684617620443472
Quick ratio: 1.2474163437464085
COGS to revenue (%): 33.503210285866004
R&D to revenue (%): 48.522750452483564
SG&A to revenue (%): 51.72656070402881
Buyback yield (%): 0
Retained earnings: -212992428.57142857
Inventory turnover: 1.928596723389186
Receivables turnover: 0.20568757433965076
Capitalized R&D asset: 30891802.653847963
ROCI (R&D-adjusted, %): -2.059295564782587
Rosenberg metric: -0.08044596350061185
Revenue growth (%): 9.317841719680471
Rule of 40 score: 9.317841719680471
Financial ratios for CMDB — quarterly report dated 2025-06-30
Total revenue: 183371764.70588237
Gross profit: 19684705.88235294
Operating income: -14047058.823529413
Net income: -31215294.11764706
Capital expenditures: 15920000
Operating cash flow: 20314117.647058822
Depreciation & amortization: 11630588.235294119
Net tangible assets: 793744705.882353
Owner earnings: -35504705.88235294
Return on net tangible assets (%): -4.473063646186431
Buffett classification: The Gruesome
Stock price: 8.67
Shares outstanding: 24240981
Book value: 793744705.8823531
P/B ratio: 0.2647819931427055
Market cap (USD): 210169305.27
Debt to equity: 0.5441236847526911
Current ratio: 1.0508256067378376
Quick ratio: 0.9228029995197814
Interest coverage ratio: -3.248979591836735
COGS to revenue (%): 89.26513800315655
SG&A to revenue (%): 1.5923934661824897
Free cash flow (dilution-adjusted): 13994117.647058824
Buyback yield (%): 0
Retained earnings: -31187058.82352941
Inventory turnover: 4.0146002250627575
Receivables turnover: 3.510890866088524
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.3930534003803479
FCF margin (%): 7.6315553103306675
Rule of 40 score: 7.6315553103306675
Financial ratios for CMDB — quarterly report dated 2025-09-30
Total revenue: 262204705.88235295
Gross profit: 30180000
Operating income: -5061176.470588235
Net income: 8651764.705882354
Capital expenditures: 34385882.35294118
Operating cash flow: 37528235.294117644
Depreciation & amortization: 10976470.588235294
Net tangible assets: 803418823.5294118
Owner earnings: -14757647.05882353
Return on net tangible assets (%): -1.8368560241087355
Buffett classification: The Gruesome
Stock price: 14.37
P/E ratio: 10.065660267354499
Shares outstanding: 24240981
Book value: 803418823.5294118
P/B ratio: 0.4335757226097003
Market cap (USD): 348342896.96999997
Debt to equity: 0.44670276729154523
Current ratio: 1.3678333971525047
Quick ratio: 1.2261591882201412
Interest coverage ratio: -1.9916666666666667
COGS to revenue (%): 88.48990909661961
SG&A to revenue (%): 1.8754991609609017
Free cash flow (dilution-adjusted): 5691764.705882354
Buyback yield (%): 0
Retained earnings: -22535294.11764706
Inventory turnover: 6.05734205595995
Receivables turnover: 5.26341394294351
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.5141345163287305
FCF margin (%): 2.1707332394088144
Revenue growth (%): 42.99077412649326
Rule of 40 score: 45.16150736590207
Financial ratios for CMDB — annual report dated 2025-12-31
Total revenue: 702615294.117647
Gross profit: 81242352.94117647
Operating income: -22174117.647058826
Net income: -43943529.4117647
Capital expenditures: 60365882.35294118
Operating cash flow: 88927058.8235294
Depreciation & amortization: 33423529.411764707
Net tangible assets: 783115294.117647
Owner earnings: -70885882.35294117
Return on net tangible assets (%): -9.051781121553732
Buffett classification: The Gruesome
Stock price: 15.41
Shares outstanding: 24240981
Book value: 783115294.117647
P/B ratio: 0.4770096051193724
Market cap (USD): 373553517.21
Debt to equity: 0.29257054779703384
Current ratio: 2.383979021887381
Quick ratio: 2.2685588101578236
Interest coverage ratio: -2.088421052631579
COGS to revenue (%): 88.43714994231637
SG&A to revenue (%): 1.7834209332192499
Free cash flow (dilution-adjusted): 49142352.941176474
Buyback yield (%): 0
Retained earnings: -43936470.5882353
Inventory turnover: 37.15038334388408
Receivables turnover: 18.76525482310061
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.3377451326950673
FCF margin (%): 6.9942048447564815
Rule of 40 score: 6.9942048447564815
Financial ratios for CMDB — quarterly report dated 2025-12-31
Total revenue: 257038823.52941176
Gross profit: 31377647.05882353
Operating income: -3065882.3529411764
Net income: -21401176.470588237
Capital expenditures: 10060000
Operating cash flow: 31061176.470588237
Depreciation & amortization: 10816470.588235294
Net tangible assets: 783115294.117647
Owner earnings: -20644705.88235294
Return on net tangible assets (%): -2.6362281566233206
Buffett classification: The Gruesome
Stock price: 15.41
Shares outstanding: 24240981
Book value: 783115294.117647
P/B ratio: 0.4770096051193724
Market cap (USD): 373553517.21
Debt to equity: 0.29257054779703384
Current ratio: 2.383979021887381
Quick ratio: 2.2685588101578236
Interest coverage ratio: -0.8169278996865204
COGS to revenue (%): 87.79264290585537
SG&A to revenue (%): 1.8257713414773689
Free cash flow (dilution-adjusted): 29432941.17647059
Buyback yield (%): 0
Retained earnings: -43936470.5882353
Inventory turnover: 13.491735246535836
Receivables turnover: 6.864921762081316
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.3232260089029788
FCF margin (%): 11.450776490619408
Revenue growth (%): -1.9701714870285485
Rule of 40 score: 9.48060500359086
Financial ratios for COD.AX — annual report dated 2021-06-30
Operating income: -4933271.428571428
Net income: -4904730.07518797
Capital expenditures: 186522.55639097744
Depreciation & amortization: 91830.07518796992
Net tangible assets: 17172390.97744361
Owner earnings: -4999422.556390977
Return on net tangible assets (%): -29.1131419204108
Buffett classification: The Gruesome
Stock price: 0.9398496240601504
Shares outstanding: 374195335
Book value: 17322430.07518797
P/B ratio: 20.302425433285855
Market cap (USD): 351687344.924812
Debt to equity: 0.008249289720937242
Current ratio: 19.55919608534071
Quick ratio: 19.55919608534071
Interest coverage ratio: -798.0115543663342
Free cash flow (dilution-adjusted): -4359498.496240601
Buyback yield (%): 0.40400696069607606
Retained earnings: -9618811.278195487
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -28.366086025025357
Rule of 40 score: 0
Financial ratios for COD.AX — annual report dated 2022-06-30
Operating income: -10351869.655172413
Net income: -9800608.27586207
Capital expenditures: 59485.51724137931
Depreciation & amortization: 101744.8275862069
Net tangible assets: 17756025.51724138
Owner earnings: -9758348.965517242
Return on net tangible assets (%): -54.95795754540751
Buffett classification: The Gruesome
Stock price: 0.17931034482758623
Shares outstanding: 374195335
Book value: 17846522.068965517
P/B ratio: 3.759673413813421
Market cap (USD): 67097094.55172415
Debt to equity: 0.00380253747499223
Current ratio: 5.307591963458444
Quick ratio: 5.307591963458444
Interest coverage ratio: -2268.4314644098536
Free cash flow (dilution-adjusted): -9953666.896551725
Buyback yield (%): 0
Retained earnings: -18623380
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -58.004969344553444
Rule of 40 score: 0
Financial ratios for COD.AX — annual report dated 2023-06-30
Operating income: -5327832.450331125
Net income: -5140837.748344371
Capital expenditures: 12127.152317880795
Depreciation & amortization: 116419.20529801324
Net tangible assets: 14952401.324503312
Owner earnings: -5036545.695364239
Return on net tangible assets (%): -33.683858438915614
Buffett classification: The Gruesome
Stock price: 0.1390728476821192
Shares outstanding: 374195335
Book value: 15030472.185430463
P/B ratio: 3.4623270770068735
Market cap (USD): 52040410.827814564
Debt to equity: 0.00033785669756181407
Current ratio: 5.843838665848579
Quick ratio: 5.843838665848579
Interest coverage ratio: -3475.1736501079913
Free cash flow (dilution-adjusted): -4982942.38410596
Buyback yield (%): 0.3395081901605774
Retained earnings: -23024215.894039735
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -35.44687342221737
Rule of 40 score: 0
Financial ratios for CPRT — annual report dated 2021-07-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 36.75
Shares outstanding: 925811482
Market cap (USD): 34023571963.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPRT — annual report dated 2022-07-31
Total revenue: 3500921000
Gross profit: 1606221000
Operating income: 1374997000
Net income: 1090130000
Capital expenditures: 333115000
Operating cash flow: 1176683000
Depreciation & amortization: 138605000
Net tangible assets: 4168965000
Owner earnings: 895620000
Return on net tangible assets (%): 21.48302996067369
Capex to operating income (%): 24.226598312578137
Buffett classification: The Great
Stock price: 32.03
P/E ratio: 27.202023399466118
Shares outstanding: 925811482
Book value: 4625599000
P/B ratio: 6.410789557949143
Market cap (USD): 29653741768.460003
Debt to equity: 0.02582865484016232
Current ratio: 4.9954863922665345
Quick ratio: 4.8621399036945805
Effective tax rate (%): 18.70489218869551
Interest coverage ratio: 82.3943552253116
COGS to revenue (%): 54.12004441117067
SG&A to revenue (%): 6.604662030362868
Free cash flow (dilution-adjusted): 800270000
Buyback yield (%): 0
Retained earnings: 3956408000
Inventory turnover: 32.22772193022742
Receivables turnover: 5.570678887112044
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 28.24576954483127
FCF margin (%): 22.858842001861795
Rule of 40 score: 22.858842001861795
Financial ratios for CPRT — annual report dated 2023-07-31
Total revenue: 3869518000
Gross profit: 1736991000
Operating income: 1486569000
Net income: 1237741000
Capital expenditures: 482717000
Operating cash flow: 1364210000
Depreciation & amortization: 159684000
Net tangible assets: 5530449000
Owner earnings: 914708000
Return on net tangible assets (%): 16.539488927571703
Capex to operating income (%): 32.47188660600349
Buffett classification: The Good
Stock price: 44.19
P/E ratio: 33.05344929963538
Shares outstanding: 925811482
Book value: 5987440000
P/B ratio: 6.8329051129664755
Market cap (USD): 40911609389.579994
Debt to equity: 0.020117612869607043
Current ratio: 6.620960328267403
Quick ratio: 6.539841183191313
Effective tax rate (%): 20.368094765068893
COGS to revenue (%): 55.11092079168517
SG&A to revenue (%): 6.47165874406063
Free cash flow (dilution-adjusted): 807901000
Buyback yield (%): 0
Retained earnings: 5189440000
Inventory turnover: 53.34918570034773
Receivables turnover: 5.460700637302219
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.803728036816004
FCF margin (%): 20.878595215218017
Revenue growth (%): 10.528572338536058
Rule of 40 score: 31.407167553754075
Financial ratios for CPRT — annual report dated 2024-07-31
Total revenue: 4236823000
Gross profit: 1907252000
Operating income: 1572023000
Net income: 1363020000
Capital expenditures: 506824000
Operating cash flow: 1472564000
Depreciation & amortization: 190256000
Net tangible assets: 6936014000
Owner earnings: 1046452000
Return on net tangible assets (%): 15.087224449085598
Capex to operating income (%): 32.24024075983621
Buffett classification: The Good
Stock price: 52.33
P/E ratio: 35.54439028998841
Shares outstanding: 925811482
Book value: 7548555000
P/B ratio: 6.418144247880554
Market cap (USD): 48447714853.06
Debt to equity: 0.015729235595421904
Current ratio: 7.028978613258412
Quick ratio: 6.959552442301298
Effective tax rate (%): 20.54437154766619
COGS to revenue (%): 54.98391129391056
SG&A to revenue (%): 7.912272946025831
Free cash flow (dilution-adjusted): 926340000
Buyback yield (%): 0
Retained earnings: 6545902000
Inventory turnover: 53.3827768738972
Receivables turnover: 5.391203712540258
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.15621608224539
FCF margin (%): 21.864024057648855
Revenue growth (%): 9.492267512387848
Rule of 40 score: 31.356291570036703
Financial ratios for CPRT — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 51.47
Shares outstanding: 925811482
Market cap (USD): 47651516978.54
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPRT — quarterly report dated 2025-01-31
Total revenue: 1163316000
Gross profit: 525553000
Operating income: 426211000
Net income: 387400000
Capital expenditures: 116222000
Operating cash flow: 178127000
Depreciation & amortization: 54260000
Net tangible assets: 7723504000
Owner earnings: 325438000
Return on net tangible assets (%): 4.213605638062724
Capex to operating income (%): 27.268653319599917
Buffett classification: The Good
Stock price: 57.93
P/E ratio: 34.61038923093702
Shares outstanding: 925811482
Book value: 8324032000
P/B ratio: 6.443062587008315
Market cap (USD): 53632259152.26
Debt to equity: 0.014343649808169887
Current ratio: 7.88832771898729
Quick ratio: 7.794508581928953
Effective tax rate (%): 16.52301798290037
COGS to revenue (%): 54.82285122872891
SG&A to revenue (%): 8.539554171007707
Free cash flow (dilution-adjusted): 52169000
Buyback yield (%): 0
Retained earnings: 7292904000
Inventory turnover: 10.796367145178765
Receivables turnover: 1.2495539670349147
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.980432849442199
FCF margin (%): 4.484508078630398
Rule of 40 score: 4.484508078630398
Financial ratios for CPRT — quarterly report dated 2025-04-30
Total revenue: 1211716000
Gross profit: 552267000
Operating income: 451545000
Net income: 406609000
Capital expenditures: 124079000
Operating cash flow: 700873000
Depreciation & amortization: 54520000
Net tangible assets: 8196176000
Owner earnings: 337050000
Return on net tangible assets (%): 4.112283582002144
Capex to operating income (%): 27.47876734323268
Buffett classification: The Good
Stock price: 61.03
P/E ratio: 34.739931203232096
Shares outstanding: 925811482
Book value: 8802697000
P/B ratio: 6.418745839651189
Market cap (USD): 56502274746.46
Debt to equity: 0.0114805723745802
Current ratio: 8.155369088706683
Quick ratio: 8.087638404460595
Effective tax rate (%): 19.38449177015298
COGS to revenue (%): 54.422736020651705
SG&A to revenue (%): 8.312343816537869
Free cash flow (dilution-adjusted): 563750000
Buyback yield (%): 0
Retained earnings: 7698639000
Inventory turnover: 14.816415026512088
Receivables turnover: 1.5989010916509092
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.008768631261585
FCF margin (%): 46.52492828352518
Revenue growth (%): 4.1605204432845415
Rule of 40 score: 50.68544872680972
Financial ratios for CPRT — quarterly report dated 2025-07-31
Total revenue: 1125097000
Gross profit: 509718000
Operating income: 412591000
Net income: 396354000
Capital expenditures: 60343000
Operating cash flow: 438476000
Depreciation & amortization: 54142000
Net tangible assets: 8606422000
Owner earnings: 390153000
Return on net tangible assets (%): 4.533277592012105
Capex to operating income (%): 14.625379613224718
Buffett classification: The Great
Stock price: 45.33
P/E ratio: 35.255661070665
Shares outstanding: 925811482
Book value: 9207491000
P/B ratio: 4.557922943292587
Market cap (USD): 41967034479.06
Debt to equity: 0.011266804387862013
Current ratio: 8.422051835189329
Quick ratio: 8.364006901992006
Effective tax rate (%): 17.37011086771124
COGS to revenue (%): 54.69563957596545
SG&A to revenue (%): 8.632766774775865
Free cash flow (dilution-adjusted): 341736000
Buyback yield (%): 0
Retained earnings: 8093069000
Inventory turnover: 15.515972870073876
Receivables turnover: 1.4738148602747478
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.385710266176752
FCF margin (%): 30.373914426933858
Revenue growth (%): -7.14845722925174
Rule of 40 score: 23.22545719768212
Financial ratios for CPRT — annual report dated 2025-07-31
Total revenue: 4646958000
Gross profit: 2099643000
Operating income: 1696714000
Net income: 1552449000
Capital expenditures: 537159000
Operating cash flow: 1799750000
Depreciation & amortization: 217784000
Net tangible assets: 8606422000
Owner earnings: 1233074000
Return on net tangible assets (%): 14.32737088653101
Capex to operating income (%): 31.658782800165497
Buffett classification: The Good
Stock price: 45.33
P/E ratio: 27.032794300527744
Shares outstanding: 925811482
Book value: 9207491000
P/B ratio: 4.557922943292587
Market cap (USD): 41967034479.06
Debt to equity: 0.011266804387862013
Current ratio: 8.422051835189329
Quick ratio: 8.364006901992006
Effective tax rate (%): 18.31723360806001
COGS to revenue (%): 54.81682855752086
SG&A to revenue (%): 8.67081217432996
Free cash flow (dilution-adjusted): 1192756000
Buyback yield (%): 0
Retained earnings: 8093069000
Inventory turnover: 64.22720052444467
Receivables turnover: 6.087258036838265
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.035526728808485
FCF margin (%): 25.66745815219333
Revenue growth (%): 9.680248620251543
Rule of 40 score: 35.34770677244487
Financial ratios for CPRT — quarterly report dated 2025-10-31
Total revenue: 1155030000
Gross profit: 536998000
Operating income: 430694000
Net income: 403714000
Capital expenditures: 100110000
Operating cash flow: 535253000
Depreciation & amortization: 54199000
Net tangible assets: 9021786000
Owner earnings: 357803000
Return on net tangible assets (%): 3.96598855259923
Capex to operating income (%): 23.243880806326533
Buffett classification: The Great
Stock price: 43.01
P/E ratio: 24.979440667433252
Shares outstanding: 925811482
Book value: 9619111000
P/B ratio: 4.139587519139762
Market cap (USD): 39819151840.82
Debt to equity: 0.010389317682268143
Current ratio: 7.939280283053165
Quick ratio: 7.8875544677648115
Effective tax rate (%): 17.431531666540074
COGS to revenue (%): 53.50787425434837
SG&A to revenue (%): 9.203570470031082
Free cash flow (dilution-adjusted): 417892000
Buyback yield (%): 0
Retained earnings: 8495453000
Inventory turnover: 15.294793110275194
Receivables turnover: 1.519254571785216
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.394918354606178
FCF margin (%): 36.18018579603993
Revenue growth (%): 2.6604817184651632
Rule of 40 score: 38.84066751450509
Financial ratios for CPRT — quarterly report dated 2026-01-31
Total revenue: 1121674000
Gross profit: 492812000
Operating income: 388710000
Net income: 350732000
Capital expenditures: 67838000
Operating cash flow: 127500000
Depreciation & amortization: 55514000
Net tangible assets: 9208280000
Owner earnings: 338408000
Return on net tangible assets (%): 3.6750402898261134
Capex to operating income (%): 17.452085102004062
Buffett classification: The Great
Stock price: 40.58
P/E ratio: 24.12303379495046
Shares outstanding: 925811482
Book value: 9807234000
P/B ratio: 3.8307875533060596
Market cap (USD): 37569429939.56
Debt to equity: 0.00980256002864824
Current ratio: 10.06100610386839
Quick ratio: 9.992799813642236
Effective tax rate (%): 20.651220159211334
COGS to revenue (%): 56.06459630873142
SG&A to revenue (%): 9.280949723359907
Free cash flow (dilution-adjusted): 47651000
Buyback yield (%): 0
Retained earnings: 8634076000
Inventory turnover: 15.019393360401242
Receivables turnover: 1.3005715133799527
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.894464822425689
FCF margin (%): 4.248204023628968
Revenue growth (%): -2.887890357826204
Rule of 40 score: 1.3603136658027646
Financial ratios for CRD.A — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.57
Shares outstanding: 29794665
Market cap (USD): 195750949.05
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRD.A — annual report dated 2022-12-31
Total revenue: 1231226000
Gross profit: 306354000
Operating income: 50604000
Net income: -18305000
Capital expenditures: 3806000
Operating cash flow: 27634000
Depreciation & amortization: 36098000
Net tangible assets: -123094000
Owner earnings: 13987000
Capex to operating income (%): 7.521144573551498
Buffett classification: The Great
Stock price: 5.04
Shares outstanding: 29794665
Book value: 123378000
P/B ratio: 1.2171141662208822
Market cap (USD): 150165111.6
Debt to equity: 2.807599409943426
Current ratio: 1.2568276878709923
Quick ratio: 1.2568276878709923
Effective tax rate (%): 467.26119698771305
Interest coverage ratio: 4.614627028998723
COGS to revenue (%): 75.11797184269989
SG&A to revenue (%): 20.771978499479378
Free cash flow (dilution-adjusted): -11888000
Buyback yield (%): 17.813059048797058
Retained earnings: 213094000
Receivables turnover: 4.453251253264274
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.883207687199718
FCF margin (%): -0.9655416633501892
Rule of 40 score: -0.9655416633501892
Financial ratios for CRD.A — annual report dated 2023-12-31
Total revenue: 1316919000
Gross profit: 359072000
Operating income: 72566000
Net income: 30609000
Capital expenditures: 4890000
Operating cash flow: 103790000
Depreciation & amortization: 35742000
Net tangible assets: -113662000
Owner earnings: 61461000
Return on net tangible assets (%): -54.07348102268128
Capex to operating income (%): 6.738693051842461
Buffett classification: The Great
Stock price: 12.32
P/E ratio: 11.992233421542686
Shares outstanding: 29794665
Book value: 139831000
P/B ratio: 2.625099389977902
Market cap (USD): 367070272.8
Debt to equity: 2.22788938075248
Current ratio: 1.2340657284524812
Quick ratio: 1.2340657284524812
Effective tax rate (%): 36.1023713495365
Interest coverage ratio: 3.663284365692362
COGS to revenue (%): 72.73393428145542
SG&A to revenue (%): 21.75577996824406
Free cash flow (dilution-adjusted): 61591000
Buyback yield (%): 0.7439992291307115
Retained earnings: 228564000
Receivables turnover: 5.209022407689417
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.515899957392076
FCF margin (%): 4.676901160967379
Revenue growth (%): 6.9599732299350405
Rule of 40 score: 11.63687439090242
Financial ratios for CRD.A — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.47
Shares outstanding: 29794665
Market cap (USD): 311950142.55
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRD.A — quarterly report dated 2024-12-31
Total revenue: 358318000
Gross profit: 94902000
Operating income: 23815000
Net income: 5861000
Capital expenditures: 3218000
Operating cash flow: 40526000
Depreciation & amortization: 9238000
Net tangible assets: -105557000
Owner earnings: 11881000
Return on net tangible assets (%): -11.255530187481645
Capex to operating income (%): 13.512492126810832
Buffett classification: The Great
Stock price: 11.1
P/E ratio: 14.1068410467497
Shares outstanding: 29794665
Book value: 155551000
P/B ratio: 2.1261244318583614
Market cap (USD): 330720781.5
Debt to equity: 1.989630410604882
Current ratio: 1.2485595224988073
Quick ratio: 1.2485595224988073
Effective tax rate (%): 38.8076842764669
Interest coverage ratio: 4.561386707527293
COGS to revenue (%): 73.51458760095781
SG&A to revenue (%): 19.83908148627755
Free cash flow (dilution-adjusted): 26375000
Buyback yield (%): 0.0795232760418474
Retained earnings: 237948000
Receivables turnover: 1.2866874221221556
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.72493591625862
FCF margin (%): 7.360780089194514
Rule of 40 score: 7.360780089194514
Financial ratios for CRD.A — annual report dated 2024-12-31
Total revenue: 1340970000
Gross profit: 367547000
Operating income: 67883000
Net income: 26596000
Capital expenditures: 6210000
Operating cash flow: 51619000
Depreciation & amortization: 36195000
Net tangible assets: -105557000
Owner earnings: 56581000
Return on net tangible assets (%): -53.60231912615932
Capex to operating income (%): 9.14809304244067
Buffett classification: The Great
Stock price: 11.1
P/E ratio: 12.434982008572717
Shares outstanding: 29794665
Book value: 155551000
P/B ratio: 2.1261244318583614
Market cap (USD): 330720781.5
Debt to equity: 1.989630410604882
Current ratio: 1.2485595224988073
Quick ratio: 1.2485595224988073
Effective tax rate (%): 35.47139521307648
Interest coverage ratio: 3.343496035068709
COGS to revenue (%): 72.5909602750248
SG&A to revenue (%): 22.346808653437435
Free cash flow (dilution-adjusted): 4204000
Buyback yield (%): 1.1692642906989503
Retained earnings: 237948000
Receivables turnover: 4.815301582513708
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.468100978517066
FCF margin (%): 0.31350440352878883
Revenue growth (%): 1.8263082239682167
Rule of 40 score: 2.1398126274970055
Financial ratios for CRD.A — quarterly report dated 2025-03-31
Total revenue: 323339000
Gross profit: 90139000
Operating income: 15552000
Net income: 6740000
Capital expenditures: 994000
Operating cash flow: -13923000
Depreciation & amortization: 9647000
Net tangible assets: -101339000
Owner earnings: 15393000
Return on net tangible assets (%): -15.189611107273606
Capex to operating income (%): 6.391460905349794
Buffett classification: The Great
Stock price: 11.03
P/E ratio: 12.189731266691393
Shares outstanding: 29794665
Book value: 159023000
P/B ratio: 2.0665888264590655
Market cap (USD): 328635154.95
Debt to equity: 2.084031869603768
Current ratio: 1.3027103329478233
Quick ratio: 1.3027103329478233
Effective tax rate (%): 26.89804772234273
Interest coverage ratio: 3.259693984489625
COGS to revenue (%): 72.1224473385518
SG&A to revenue (%): 23.06774004991665
Free cash flow (dilution-adjusted): -24636000
Buyback yield (%): 0
Retained earnings: 241177000
Receivables turnover: 1.1734781646155354
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.0731655264811546
FCF margin (%): -7.619247910088174
Revenue growth (%): -9.761999118101798
Rule of 40 score: -17.38124702818997
Financial ratios for CRD.A — quarterly report dated 2025-06-30
Total revenue: 334595000
Gross profit: 98273000
Operating income: 17523000
Net income: 7820000
Capital expenditures: 1407000
Operating cash flow: 35006000
Depreciation & amortization: 9814000
Net tangible assets: -87806000
Owner earnings: 16227000
Return on net tangible assets (%): -18.480513860100675
Capex to operating income (%): 8.02944701249786
Buffett classification: The Great
Stock price: 10.29
P/E ratio: 15.013324658439839
Shares outstanding: 29794665
Book value: 175341000
P/B ratio: 1.748519187468989
Market cap (USD): 306587102.84999996
Debt to equity: 1.7650806143457605
Current ratio: 1.3381701113443136
Quick ratio: 1.3381701113443136
Effective tax rate (%): 42.77350896450787
Interest coverage ratio: 3.765148259561667
COGS to revenue (%): 70.6292682197881
SG&A to revenue (%): 24.133654119158983
Free cash flow (dilution-adjusted): 24146000
Buyback yield (%): 0
Retained earnings: 245497000
Receivables turnover: 1.169050106390041
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.3811540650837903
FCF margin (%): 7.216485601996443
Revenue growth (%): 3.481176103099224
Rule of 40 score: 10.697661705095667
Financial ratios for CRD.A — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.48
P/E ratio: 15.290538622006757
Shares outstanding: 29794665
Market cap (USD): 312248089.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRD.A — quarterly report dated 2025-12-31
Total revenue: 320086000
Gross profit: 84884000
Operating income: 20245000
Net income: -7240000
Capital expenditures: 3249000
Operating cash flow: 50132000
Depreciation & amortization: 10498000
Net tangible assets: -82640000
Owner earnings: 9000
Capex to operating income (%): 16.04840701407755
Buffett classification: The Great
Stock price: 11.09
P/E ratio: 45.13973153688524
Shares outstanding: 29794665
Book value: 171432000
P/B ratio: 1.9274279880652387
Market cap (USD): 330422834.85
Debt to equity: 1.5765668019972934
Current ratio: 1.1383919630455148
Quick ratio: 1.1383919630455148
Interest coverage ratio: 5.113665066936095
COGS to revenue (%): 73.48087701430241
SG&A to revenue (%): 20.194260292546378
Free cash flow (dilution-adjusted): 38812000
Buyback yield (%): 2.2882801073456136
Retained earnings: 233708000
Receivables turnover: 1.2960469042924068
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.452092450465111
FCF margin (%): 12.125491274220053
Rule of 40 score: 12.125491274220053
Financial ratios for CRD.A — annual report dated 2025-12-31
Total revenue: 1310827000
Gross profit: 367088000
Operating income: 72922000
Net income: 19676000
Capital expenditures: 7014000
Operating cash flow: 101847000
Depreciation & amortization: 40043000
Net tangible assets: -82640000
Owner earnings: 52705000
Return on net tangible assets (%): -63.776621490803485
Capex to operating income (%): 9.61849647568635
Buffett classification: The Great
Stock price: 11.09
P/E ratio: 16.793191443891036
Shares outstanding: 29794665
Book value: 171432000
P/B ratio: 1.9274279880652387
Market cap (USD): 330422834.85
Debt to equity: 1.5765668019972934
Current ratio: 1.1383919630455148
Quick ratio: 1.1383919630455148
Effective tax rate (%): 43.13294797687861
Interest coverage ratio: 4.057308184498971
COGS to revenue (%): 71.99569432121858
SG&A to revenue (%): 22.44125273586827
Free cash flow (dilution-adjusted): 58105000
Buyback yield (%): 3.1819834742271893
Retained earnings: 233708000
Receivables turnover: 5.30761506411684
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.036329250324368
FCF margin (%): 4.432697831216476
Revenue growth (%): -2.2478504366242347
Rule of 40 score: 2.1848473945922415
Financial ratios for DKS — annual report dated 2022-01-31
Capital expenditures: 0
Depreciation & amortization: 322551000
Buffett classification: The Gruesome
Stock price: 103.89
Shares outstanding: 65931904
Market cap (USD): 6849665506.56
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DKS — annual report dated 2023-01-31
Total revenue: 12368198000
Gross profit: 4284558000
Operating income: 1484705000
Net income: 1043138000
Capital expenditures: 364075000
Operating cash flow: 921881000
Depreciation & amortization: 365475000
Net tangible assets: 2218402000
Owner earnings: 1044538000
Return on net tangible assets (%): 47.08515408839335
Capex to operating income (%): 24.52170633223435
Buffett classification: The Great
Stock price: 119.98
P/E ratio: 7.583378078375057
Shares outstanding: 65931904
Book value: 2524623000
P/B ratio: 3.1333430147471524
Market cap (USD): 7910509841.92
Debt to equity: 1.665648692893949
Current ratio: 1.8789655363009503
Quick ratio: 0.807235506612666
Effective tax rate (%): 24.615031060568832
Interest coverage ratio: 15.592365049359378
COGS to revenue (%): 65.35826803548909
SG&A to revenue (%): 22.637517607657962
Free cash flow (dilution-adjusted): 507203000
Buyback yield (%): 5.795530366077211
Retained earnings: 4878404000
Inventory turnover: 2.855484636250374
Receivables turnover: 155.6276722912184
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.3784198716687
FCF margin (%): 4.1008641679248665
Rule of 40 score: 4.1008641679248665
Financial ratios for DKS — annual report dated 2024-01-31
Total revenue: 12984399000
Gross profit: 4533735000
Operating income: 1350205000
Net income: 1046519000
Capital expenditures: 587426000
Operating cash flow: 1527335000
Depreciation & amortization: 393933000
Net tangible assets: 2314761000
Owner earnings: 853026000
Return on net tangible assets (%): 36.85157992553011
Capex to operating income (%): 43.50643050499739
Buffett classification: The Good
Stock price: 141.01
P/E ratio: 8.883792633521226
Shares outstanding: 65931904
Book value: 2617281000
P/B ratio: 3.5521817424418693
Market cap (USD): 9297057783.039999
Debt to equity: 1.6291066950778308
Current ratio: 1.7766529791882995
Quick ratio: 0.7416278338057706
Effective tax rate (%): 20.607047295795397
Interest coverage ratio: 23.270168726194786
COGS to revenue (%): 65.08321255377318
SG&A to revenue (%): 24.51811593282061
Free cash flow (dilution-adjusted): 882624000
Buyback yield (%): 6.975905874040212
Retained earnings: 5588914000
Inventory turnover: 2.966397395110989
Receivables turnover: 109.12635206118418
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.584407803324655
FCF margin (%): 6.797572995099735
Revenue growth (%): 4.982140486431411
Rule of 40 score: 11.779713481531147
Financial ratios for DKS — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 187.99
Shares outstanding: 65931904
Market cap (USD): 12394538632.960001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DKS — quarterly report dated 2025-01-31
Total revenue: 3893649000
Gross profit: 1361258000
Operating income: 397678000
Net income: 299970000
Capital expenditures: 236996000
Operating cash flow: 631528000
Depreciation & amortization: 110049000
Net tangible assets: 2893809000
Owner earnings: 173023000
Return on net tangible assets (%): 5.9790746383054305
Capex to operating income (%): 59.59494867707039
Buffett classification: The Good
Stock price: 231.7
P/E ratio: 12.731624959829315
Shares outstanding: 65931904
Book value: 3198264000
P/B ratio: 4.776473160689673
Market cap (USD): 15276422156.8
Debt to equity: 1.403186228528977
Current ratio: 1.7589603715769357
Quick ratio: 0.6713751216696288
Effective tax rate (%): 24.492729181192782
Interest coverage ratio: 31.355199873846882
COGS to revenue (%): 65.03901610032132
SG&A to revenue (%): 24.74747980621777
Free cash flow (dilution-adjusted): 374247000
Buyback yield (%): 0.6071644200976262
Retained earnings: 6392513000
Inventory turnover: 0.7559759749002188
Receivables turnover: 17.765428662681938
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.389589831827905
FCF margin (%): 9.61172925448596
Rule of 40 score: 9.61172925448596
Financial ratios for DKS — annual report dated 2025-01-31
Total revenue: 13442849000
Gross profit: 4825696000
Operating income: 1531424000
Net income: 1165308000
Capital expenditures: 802565000
Operating cash flow: 1311835000
Depreciation & amortization: 400409000
Net tangible assets: 2893809000
Owner earnings: 763152000
Return on net tangible assets (%): 26.37188563585226
Capex to operating income (%): 52.40645307896441
Buffett classification: The Good
Stock price: 231.7
P/E ratio: 13.109342900589372
Shares outstanding: 65931904
Book value: 3198264000
P/B ratio: 4.776473160689673
Market cap (USD): 15276422156.8
Debt to equity: 1.403186228528977
Current ratio: 1.7589603715769357
Quick ratio: 0.6713751216696288
Effective tax rate (%): 23.286195889095236
Interest coverage ratio: 28.90188159359843
COGS to revenue (%): 64.1021334093688
SG&A to revenue (%): 24.505757670862778
Free cash flow (dilution-adjusted): 438269000
Buyback yield (%): 1.721744773090873
Retained earnings: 6392513000
Inventory turnover: 2.572415018075544
Receivables turnover: 61.335260300223574
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.75484995050573
FCF margin (%): 3.260238956786616
Revenue growth (%): 3.5307756639333094
Rule of 40 score: 6.791014620719926
Financial ratios for DKS — quarterly report dated 2025-04-30
Total revenue: 3174677000
Gross profit: 1165086000
Operating income: 379558000
Net income: 264288000
Capital expenditures: 264725000
Operating cash flow: 178046000
Depreciation & amortization: 97860000
Net tangible assets: 2747939000
Owner earnings: 97423000
Return on net tangible assets (%): 3.5453115953447294
Capex to operating income (%): 69.74559882811059
Buffett classification: The Good
Stock price: 182.26
P/E ratio: 11.367096522581425
Shares outstanding: 65931904
Book value: 3052394000
P/B ratio: 3.93682755995458
Market cap (USD): 12016748823.039999
Debt to equity: 1.4965918554419908
Current ratio: 1.616371703167215
Quick ratio: 0.4695617781539054
Effective tax rate (%): 23.994455340760723
Interest coverage ratio: 31.270225737353766
COGS to revenue (%): 63.30064444351346
SG&A to revenue (%): 24.74355658859153
Free cash flow (dilution-adjusted): -105859000
Buyback yield (%): 2.5270645535817837
Retained earnings: 6559483000
Inventory turnover: 0.5630126804493699
Receivables turnover: 12.177884246543814
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.183686842262321
FCF margin (%): -3.3344809566453533
Revenue growth (%): -18.4652494356836
Rule of 40 score: -21.799730392328954